tiprankstipranks
Agios Pharmaceuticals completes enrollment of Phase 3 RISE UP study
PremiumThe FlyAgios Pharmaceuticals completes enrollment of Phase 3 RISE UP study
1M ago
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
Premium
The Fly
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
1M ago
Agios Pharmaceuticals initiated with an Outperform at Scotiabank
Premium
The Fly
Agios Pharmaceuticals initiated with an Outperform at Scotiabank
1M ago
Agios Pharmaceuticals price target raised to $57 from $52 at BofA
PremiumThe FlyAgios Pharmaceuticals price target raised to $57 from $52 at BofA
2M ago
Agios Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Agios Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
2M ago
Agios Pharmaceuticals announces FDA granted ODD to AG-946
Premium
The Fly
Agios Pharmaceuticals announces FDA granted ODD to AG-946
2M ago
Agios Pharmaceuticals reports Q2 EPS ($1.69), consensus ($1.60)
PremiumThe FlyAgios Pharmaceuticals reports Q2 EPS ($1.69), consensus ($1.60)
4M ago
AGIO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AGIO Earnings this Week: How Will it Perform?
4M ago
Royalty Pharma price target raised to $51 from $48 at Morgan Stanley
Premium
The Fly
Royalty Pharma price target raised to $51 from $48 at Morgan Stanley
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100